21 Code of Federal Regulations Part 11–Compliant Digital Signature Solution for Cancer Clinical Trials: A Single-Institution Feasibility Study

Author:

Miller Therica M.1ORCID,Lester Jenny2,Kwan Lorna3ORCID,Tandel Megha D.3,Karlan Beth Y.2,Rimel BJ4ORCID

Affiliation:

1. Hartford Healthcare Cancer Institute, Hartford, CT

2. Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA

3. Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA

4. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, CA

Abstract

PURPOSE Inefficiencies in the clinical trial infrastructure result in protracted trial completion timelines, physician-investigator turnover, and a shrinking skilled labor force and present obstacles to research participation. Taken together, these barriers hinder scientific progress. Technological solutions to improve clinical trial efficiency have emerged, yet adoption remains slow because of concerns with cost, regulatory compliance, and implementation. METHODS A prospective pilot study that compared regulatory-compliant digital and traditional wet ink paper signatures was conducted over a 6.5-month period in a hospital-based health system. Staff time and effort, error rate, costs, and time to completion were measured. Wilcoxon rank sum tests were used to compare staff time and time to completion. A value analysis was conducted. A survey was administered to measure user satisfaction. RESULTS There where 96 participants (47 digital, 49 paper), 132 studies included (31 digital, 101 paper), and 265 documents processed (156 digital, 109 paper). A moderate reduction in staff time required to prepare documents for signature was observed ( P < .0001). Error rates were reported in 5.1% of digital and 2.8% of paper documents, but this difference was not significant. Discrepancies requiring revisions included incomplete mandatory fields, inaccurate information submitted, and technical issues. A value analysis demonstrated a 19% labor savings with the use of digital signatures. Survey response rate was 57.4% (n = 27). Most participants (85.2%) preferred digital signatures. The time to complete documents was faster with digital signatures compared with paper ( P = .0241). CONCLUSION The use of digital signatures resulted in a decrease in document completion time and regulatory burden as represented by staff hours. Additional cost and time savings and information liquidity could be realized by integrating digital signatures and electronic document management systems.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

General Medicine

Reference4 articles.

1. American Cancer Society Cancer Action Network: Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer: A Landscape Report. Washington, DC, American Cancer Society Cancer Action Network, 2018

2. Institute of Medicine: Transforming clinical research in the United States: Challenges and opportunities: Workshop summary, in Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation. Washington, DC, National Academies Press, 2010, p 3

3. 11. Hahm J, Ommaya A (eds): The clinical research workforce: Across-the-board challenges, in: Opportunities to Address Clinical Research Workforce Diversity Needs for 2010, 2006. https://www.ncbi.nlm.nih.gov/books/NBK20276

4. Continuum Clinical: Survey Shows One Third of Clinical Trial Study Sites Fear Total Closure; 77% Indicate at Least Some Ongoing Research Trials Have Been Impacted Due to COVID-19. Washington, DC, Association of Clinical Research Professionals, 2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3